mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.3 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.3 |
mRNA |
itraconazole |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.3 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.3 |
mRNA |
Bosutinib |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.3 |
mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.3 |